ABSTRACT
Intravitreal injections (IVIâs) have gained increased popularity in the past decades and are used to treat a multitude of ailments. In 2010, the total number of IVIâs surpassed the number of cataract surgeries performed, making it the most common procedure in ophthalmology. As the number of injections increases, so does the number of injected-related complications. While complications in the posterior segment, such as retinal detachment or endophthalmitis, are detrimental to visual function and have therefore been well documented, IVIâs can also lead to complications in the anterior segment. These include hyphema, inflammation of the sterile anterior segment (incidence rate of 0.05 to 1.1% depending on the drug), implant migration with corneal decompensation (incidence rate of 0.43%), iatrogenic lens damage (incidence rate of 0.07%), accelerated cataract formation (up to 50% for steroids and 10.9% for anti-VEGF), and an increased complication rate during subsequent cataract surgery (up to 4% per IVI). Most of these complications occur immediately and have a good prognosis if treated correctly. However, the increased risk of complications during subsequent surgery demonstrates that IVIâs can also have long-term complications, a topic that needs to be explored further in future research projects.
Subject(s)
Anterior Eye Segment , Intravitreal Injections , Humans , Intravitreal Injections/adverse effects , Anterior Eye Segment/diagnostic imaging , Hyphema/etiology , Cataract/chemically induced , Endophthalmitis/etiology , Postoperative Complications/etiologyABSTRACT
The characteristics of patients with endophthalmitis due to penetrating ocular trauma are still limited. The aim of the study was to fill these gaps among Chinese population. This retrospective study included patients diagnosed as penetrating ocular traumatic endophthalmitis between January 2016 to December 2018. During the past 3-year period, a total of 201 patients with antecedent penetrating eye injuries were evaluated. Of which, 42 (20.9%) patients presented a clinical course compatible with acute infectious endophthalmitis. 39 (92.86%) patients were males, and 15 (35.71%) patients had mechanical injuries from intraocular foreign body (IOFB), the rate of endophthalmitis due to IOFB was 13.43%, higher to the rate among patients without IOFB (7.46%). The duration between injury occurrence and endophthalmitis onset was 1 day in 10 (23,80%) patients; 2 to 7 days in 31 (73.80%) patients, and 7 to 14 days in 1 (2.38%) patient. After 1 year follow-up, best corrected visual acuity (BCVA) better than 20/400 was observed in 15 (35.71%) patients, counting fingers and hand move in 17 (40.48%) patients, light perception in 5 (11.9%) patients and no light perception in 5 (11.9%) patients, respectively. Patients with promising outcomes had better initial BCVA at baseline (Pâ <â .001). Endophthalmitis is a severe ocular infectious condition that may lead to irreversible vision loss. A greater attention must be paid to penetrating eye injuries within males, who had poor BCVA at baseline, particularly with obvious IOFB.
Subject(s)
Endophthalmitis , Eye Foreign Bodies , Eye Injuries, Penetrating , Visual Acuity , Humans , Endophthalmitis/epidemiology , Endophthalmitis/etiology , Male , Eye Injuries, Penetrating/epidemiology , Eye Injuries, Penetrating/complications , Female , Retrospective Studies , Adult , Eye Foreign Bodies/epidemiology , Middle Aged , China/epidemiology , Young Adult , AdolescentABSTRACT
PURPOSE: To evaluate clinical features, treatment protocol, outcomes, and complications that developed in this case series of 24 patients who had consecutive sterile endophthalmitis after intravitreal bevacizumab (IVB) injection. METHODS: In this retrospective case series, IVB was repackaged in individual aliquots from the three batches that were used on the same day. IVB was injected into 26 eyes of 26 patients due to diabetic macular edema, age-related macular degeneration, and branch retinal vein occlusion. All patients had intraocular inflammation. Patients were divided into two groups severe and moderate inflammation according to the intraocular inflammation. The medical records of all patients were reviewed. At each follow-up visit, the complete ophthalmologic examination was performed, including best corrected visual acuity (BCVA), intraocular pressure, biomicroscopy, and posterior fundus examination. RESULTS: Twenty-four of 26 patients were included in the study. Two patients were excluded from this study since they didn't come to follow-up visits. The mean BCVA was 1.00 ± 0.52 Log MAR units before IVB. At the final visit, the BCVA was 1.04 ± 0.47 Log MAR units. These differences were not significant (p = 0.58). Of the 24 eyes, 16 eyes had severe, and 8 eyes had moderate intraocular inflammation. Eleven eyes in the severe inflammation group underwent pars plana vitrectomy due to intense vitreous opacity. Smear, culture results, and polymerase chain reaction results were negative. CONCLUSION: Sterile endophthalmitis may occur after IVB injection. Differential diagnosis of sterile endophthalmitis from infective endophthalmitis is crucial to adjust the appropriate treatment and prevent long-term complications due to unnecessary treatment.
Subject(s)
Angiogenesis Inhibitors , Bevacizumab , Endophthalmitis , Intravitreal Injections , Visual Acuity , Humans , Bevacizumab/administration & dosage , Bevacizumab/adverse effects , Endophthalmitis/diagnosis , Endophthalmitis/etiology , Retrospective Studies , Male , Female , Angiogenesis Inhibitors/administration & dosage , Angiogenesis Inhibitors/adverse effects , Aged , Middle Aged , Aged, 80 and over , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Macular Edema/drug therapy , Macular Edema/diagnosis , Macular Edema/etiology , Retinal Vein Occlusion/diagnosis , Retinal Vein Occlusion/drug therapy , Retinal Vein Occlusion/complications , Follow-Up Studies , Diabetic Retinopathy/diagnosis , Diabetic Retinopathy/drug therapyABSTRACT
PURPOSE: To assess the safety and efficacy of transzonular moxifloxacin and dexamethasone versus standard postoperative topical drug regimen in phacoemulsification. DESIGN: Nonrandomized prospective study. METHODS: The study included 100 eyes of 100 age and gender-matched individuals with senile cataract undergoing routine phacoemulsification. The patients were consecutively divided into transzonular (TZ = 50) and topical (TP = 50) groups. Both the groups were followed up for 4 weeks and assessed for intraocular inflammation, visual acuity, changes in intraocular pressure (IOP), and any adverse events. RESULTS: The grades of inflammation were significantly lower in TZ as compared to the TP group ( P < 0.001). The IOP remained normal and comparable in both the groups. Most of the patients in the two groups attained a visual acuity of 0.2 or better at the end of the follow-up. No adverse effects and increased rate of endophthalmitis were noted in TZ group. CONCLUSION: A one-time peroperative TZ moxifloxacin and dexamethasone combination is a safe and effective method to control postoperative inflammation after cataract surgery. A word of caution though, due precautions to be exercised to prevent the risk of inflammation and endophthalmitis.
Subject(s)
Dexamethasone , Fluoroquinolones , Glucocorticoids , Moxifloxacin , Phacoemulsification , Visual Acuity , Humans , Moxifloxacin/administration & dosage , Phacoemulsification/methods , Dexamethasone/administration & dosage , Female , Male , Prospective Studies , Aged , Fluoroquinolones/administration & dosage , Glucocorticoids/administration & dosage , Follow-Up Studies , Middle Aged , Drug Therapy, Combination , Treatment Outcome , Ophthalmic Solutions/administration & dosage , Intraocular Pressure/physiology , Postoperative Complications/prevention & control , Endophthalmitis/prevention & control , Endophthalmitis/etiologyABSTRACT
PURPOSE: To evaluate the importance of the status of posterior vitreous in eyes with endophthalmitis following intravitreal anti-vascular endothelial growth factor (anti-VEGF). METHODS: The absence or existence of posterior vitreous detachment (PVD) was elicited in 23 eyes of 23 patients with injection related endophthalmitis, during pars plana vitrectomy (PPV) and compared with 24 control eyes of 24 patients who received intravitreal anti-VEGF without any complication. RESULTS: Thirtten (54.2%) out of 24 patients in the control group had full PVD, whereas only 2 (9.5%) out of 23 eyes in endophthalmitis group (p < 0.001) had full PVD. In all eyes without PVD, posterior vitreous was inducted to be detached at least from optic nerve and macular area without any iatrogenic tear. CONCLUSION: The absence of PVD is a factor that increases the risk of endophthalmitis after intravitreal injections. Uncomplicated separation of the posterior vitreous from the retina in PPV contributes to better prognosis.
Subject(s)
Endophthalmitis , Intravitreal Injections , Vascular Endothelial Growth Factor A , Vitrectomy , Vitreous Detachment , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Angiogenesis Inhibitors/administration & dosage , Angiogenesis Inhibitors/adverse effects , Bevacizumab/administration & dosage , Bevacizumab/adverse effects , Endophthalmitis/etiology , Endophthalmitis/diagnosis , Endophthalmitis/epidemiology , Intravitreal Injections/adverse effects , Ranibizumab/administration & dosage , Ranibizumab/adverse effects , Risk Factors , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Vitrectomy/adverse effects , Vitrectomy/methods , Vitreous BodyABSTRACT
Background: Where routine prophylactic antibiotics have been adopted following cataract surgery, rates of endophthalmitis have been decreasing. Intracameral and topical antibiotics are currently used to prevent endophthalmitis after cataract surgery. When applying topical antibiotics, there are different recommendations on the frequency and duration of therapy. The development of bacterial resistance to the excessive and long-term use of antibiotics is a growing problem worldwide. The goal is to achieve a good antibiotic effect with the shortest possible use of antibiotics. Objective: The aim of this study was to compare the effectiveness of a new combination therapy of dexamethasone and levofloxacin for seven days after cataract surgery with the previous regimen of dexamethasone, neomycin sulfate, and polymyxin B, which was given for 21 days. Methods: A retrospective analysis of medical records and administered a questionnaire was conducted to assess the effectiveness of postoperative therapy in our cataract surgery patients. The study involved 52 patients who underwent surgery within the last year, performed by a single surgeon at our institution. The findings can help us improve the quality of care we provide and optimize our patients' overall quality of life. Results: We conducted an in-depth study on 52 individuals who underwent cataract surgery at our institution. The prescribed therapeutic regimen for the participants included administering Ducressa solution four times daily for the first seven days and Maxidex solution three times daily for the subsequent 14 days. The study found that none of the participants experienced complications after surgery, and all found it easy to instill the medication. The prescribed regimen effectively managed the postoperative recovery of the participants, and the medication was well-tolerated. Conclusion: Our research found that a new combination of levofloxacin and dexamethasone, when used topically, may require a shorter treatment period, reducing the risk of antibiotic resistance and providing a safe alternative for endophthalmitis prevention.
Subject(s)
Cataract Extraction , Cataract , Endophthalmitis , Humans , Levofloxacin/therapeutic use , Retrospective Studies , Quality of Life , Postoperative Complications/etiology , Anti-Bacterial Agents/therapeutic use , Cataract Extraction/adverse effects , Dexamethasone/therapeutic use , Endophthalmitis/drug therapy , Endophthalmitis/etiology , Endophthalmitis/prevention & control , Cataract/etiologyABSTRACT
Objectives: The first purpose is to present the diagnosis and therapeutic approach in a patient with sterile endophthalmitis associated with triamcinolone acetonide injection. The secondary objective is to assess the incidence of this complication and to summarize the risk factors described in the literature. Case presentation: A 76-year-old male patient presented for painless, unilateral, decreased visual acuity, four days after cataract surgery and simultaneously intravitreal triamcinolone acetonide injection for diabetic macular edema in the right eye. The diagnosis of sterile endophthalmitis was made. Eight days after the presentation, the symptoms subsided, the maximum corrected visual acuity reaching that before the procedures. Discussions: The incidence of sterile endophthalmitis varies in the literature between 0% and 23.8%. Visual prognosis is good, although the pathogenesis is not fully understood. Preservatives in injectable solutions have been suggested, however, there are studies in which inflammation was also present with preservative-free products. The particle size of triamcinolone was analyzed, demonstrating an association between smaller particles and an increased frequency of adverse reactions of this type. History of uveitis, posterior capsule rupture following cataract surgery, and Irvine-Gass syndrome are other associations described. Conclusion: The physiopathological mechanism of sterile endophthalmitis is not fully understood. However, the visual prognosis is good, the final vision being dependent on the underlying pathology.
Subject(s)
Cataract , Diabetic Retinopathy , Endophthalmitis , Macular Edema , Male , Humans , Aged , Triamcinolone Acetonide/adverse effects , Intravitreal Injections , Macular Edema/diagnosis , Macular Edema/drug therapy , Macular Edema/etiology , Endophthalmitis/diagnosis , Endophthalmitis/etiologySubject(s)
Aggregatibacter actinomycetemcomitans , Endocarditis, Bacterial , Endophthalmitis , Pasteurellaceae Infections , Humans , Endophthalmitis/microbiology , Endophthalmitis/diagnosis , Endophthalmitis/etiology , Endocarditis, Bacterial/microbiology , Endocarditis, Bacterial/complications , Endocarditis, Bacterial/diagnosis , Pasteurellaceae Infections/diagnosis , Pasteurellaceae Infections/complications , Pasteurellaceae Infections/microbiology , Aggregatibacter actinomycetemcomitans/isolation & purification , Male , Female , Eye Infections, Bacterial/diagnosis , Eye Infections, Bacterial/microbiologyABSTRACT
A 71-year-old woman had 2 months of worsening vision and pain in her right eye. Examination revealed retrocorneal plaque, peaking of the pupil, and temporal prominent scleral vessels with inferotemporal scleral thinning. What would you do next?
Subject(s)
Anterior Eye Segment , Postoperative Complications , Humans , Anterior Eye Segment/diagnostic imaging , Anterior Eye Segment/pathology , Female , Male , Aged , Middle Aged , Inflammation/etiology , Endophthalmitis/etiology , Endophthalmitis/diagnosis , Uveitis, Anterior/etiology , Uveitis, Anterior/diagnosis , Trabeculectomy/adverse effectsABSTRACT
Universal mask wear is an effective public health intervention to reduce SARS-Cov-2 transmission, especially in enclosed public spaces and healthcare environments. Concerns have been raised about possible transmission of the SARS-Cov-2 through ocular secretions, leading to enhanced protective measures during ophthalmic procedures. However, there is some evidence for air jets from the upper edge of the surgical mask to the ocular surface, especially when the mask is not well fit. Prolonged airflow towards the ocular surface during expiration may alter tear-film stability, leading to hyperosmolarity and ocular surface inflammation. This also raises the question of whether the ocular surface is contaminated with oral flora from airflow directed toward the eyes, thus increasing the risk of ocular infection. Herein we review the impact of patient face mask wear on the ocular surface, eyelids and risk of ocular infection, particularly during ocular surgery. There is some evidence for increased incidence of dry eye or eyelid disease during periods of mandatory face mask wear. While high daily exposure is consistent with a direct association, this should be mitigated by various cofounding factors which could also affect the ocular health during the COVID-19 pandemic. An increased risk of post-intravitreal injection endophthalmitis, possibly due to face mask wear by the patient, including culture-positive endophthalmitis, has been reported in one retrospective study. Several measures have been shown to prevent or limit the risk of developing dry eye disease or exacerbation, eyelid cyst, and ocular infection during intravitreal injections.
Subject(s)
COVID-19 , Masks , Pandemics , SARS-CoV-2 , Humans , COVID-19/prevention & control , COVID-19/transmission , COVID-19/epidemiology , Masks/adverse effects , Pandemics/prevention & control , Dry Eye Syndromes/epidemiology , Dry Eye Syndromes/etiology , Endophthalmitis/epidemiology , Endophthalmitis/prevention & control , Endophthalmitis/etiologySubject(s)
Endophthalmitis , Uveitis , Humans , Endophthalmitis/etiology , Uveitis/etiology , Uveitis/complications , Male , Female , PhacoemulsificationSubject(s)
Communicable Diseases , Endophthalmitis , Epidural Abscess , Spondylarthritis , Humans , Epidural Abscess/diagnosis , Epidural Abscess/drug therapy , Anti-Bacterial Agents/therapeutic use , Communicable Diseases/drug therapy , Endophthalmitis/diagnosis , Endophthalmitis/drug therapy , Endophthalmitis/etiology , Spondylarthritis/diagnosis , Spondylarthritis/drug therapyABSTRACT
A woman in her 70s was hospitalized and was diagnosed with liver abscess and managed with antibiotics in a previous hospital. However, she experienced altered consciousness and neck stiffness during treatment. She was then referred to our hospital. On investigation, we found that she had meningitis and right endophthalmitis concurrent with a liver abscess. Klebsiella pneumoniae was detected from both cultures of the liver abscess and effusion from the cornea. A string test showed a positive result. Therefore, she was diagnosed with invasive liver abscess syndrome. Although she recovered from the liver abscess and meningitis through empiric antibiotic treatment, her right eye required ophthalmectomy. In cases where a liver abscess presents with extrahepatic complications, such as meningitis and endophthalmitis, the possibility of invasive liver abscess syndrome should be considered, which is caused by a hypervirulent K. pneumoniae.
Subject(s)
Endophthalmitis , Klebsiella Infections , Liver Abscess , Meningitis , Female , Humans , Anti-Bacterial Agents/therapeutic use , Endophthalmitis/etiology , Endophthalmitis/complications , Klebsiella Infections/complications , Klebsiella Infections/drug therapy , Klebsiella Infections/diagnosis , Klebsiella pneumoniae , Liver Abscess/diagnostic imaging , Liver Abscess/etiology , Meningitis/complications , Meningitis/drug therapy , AgedABSTRACT
BACKGROUND: The most feared complication of intravitreal injections is the development of endophthalmitis, which could lead to irreversible visual loss. The aim of this study was to characterize the clinical profiles, causative pathogens, and clinical outcome of patients post-endophthalmitis. METHODS: Retrospective, single center case series study. Clinical records, causative pathogens and management of all cases of endophthalmitis post intravitreal anti-vascular endothelial growth factor (VEGF) injections recorded between January 1st, 2006 and May 30th, 2022; were retrieved. The visual and anatomic changes prior to the episode of endophthalmitis and up to 2 years post-treatment were compared. RESULTS: Eleven post-injection endophthalmitis eyes of 10 patients (n = 3 females; 30%) were recruited at mean age of 64.5 ± 20.4 years. The median last recorded BCVA, up to 3 months prior to the episode of endophthalmitis was 60 (Interquartile range (IQR) 55-75) ETDRS letters. Then, it dropped to 30 (IQR 0-57.5), 35 (IQR 0-52.5) and 35 (IQR 0-57.5) ETDRS letters at presentation, 6- and 12-months follow-up; respectively (p = 0.027, p = 0.017 and p = 0.012). However, at 24 months, the median BCVA returned to similar baseline values prior to the episode of endophthalmitis; BCVA 50 (IQR 0-60) ETDRS letters, p = 0.062. Interestingly, two eyes with neovascular age-related macular degeneration (NVAMD), 1 with myopic choroidal neovascularization (CNV) and 1 with retinal vein occlusion (RVO), experienced disease quiescence and did not require additional anti-VEGF injections up to 2 years of follow-up. CONCLUSION: This study demonstrates long-term recovery of vision loss due to endophthalmitis post anti-VEGF injections, regained up to 2 years later. It also indicates that disease quiescence post endophthalmitis may not only occur in eyes treated for NVAMD, but also with myopic CNV and RVO.
Subject(s)
Choroidal Neovascularization , Endophthalmitis , Retinal Vein Occlusion , Female , Humans , Adult , Middle Aged , Aged , Aged, 80 and over , Ranibizumab/therapeutic use , Angiogenesis Inhibitors , Bevacizumab/therapeutic use , Vascular Endothelial Growth Factor A , Retrospective Studies , Retinal Vein Occlusion/drug therapy , Choroidal Neovascularization/drug therapy , Intravitreal Injections , Endophthalmitis/etiology , Endophthalmitis/complicationsABSTRACT
PURPOSE: To review the risk of endophthalmitis in same-day bilateral anti-VEGF injections. METHODS: We searched 12 literature databases for studies on the risk of endophthalmitis after same-day bilateral intravitreal anti-VEGF injections. Data extraction was made independently by two authors and discussed afterward until reaching consensus. RESULTS: Seventeen studies were included with a total of 138,478 intravitreal anti-VEGF injections (69,239 bilateral injections sessions) given in at least 7579 patients. In total, 33 cases of endophthalmitis had occurred, and no cases were bilateral. The incidence of endophthalmitis ranged from 0 to 0.53% per intravitreal injection across studies. CONCLUSIONS: We suggest that clinicians can consider same-day treatment of both eyes of patients in need of bilateral intravitreal anti-VEGF injection therapy, but larger studies are needed to quantify the exact risk of endophthalmitis.
Subject(s)
Endophthalmitis , Ranibizumab , Humans , Ranibizumab/adverse effects , Angiogenesis Inhibitors , Bevacizumab/adverse effects , Vascular Endothelial Growth Factor A , Endophthalmitis/epidemiology , Endophthalmitis/etiology , Endophthalmitis/drug therapy , Intravitreal Injections , Retrospective Studies , IncidenceABSTRACT
PURPOSE: The authors sought to determine if universal face mask guidelines implemented during the coronavirus disease 2019 pandemic significantly influenced the incidence of endophthalmitis following intravitreal injections (IVI). METHODS: This retrospective cohort study reviewed the electronic health records from a retina-only practice located in Michigan. This study evaluated patients receiving IVIs over two distinct time periods of April 2019 to March 2020 and April 2020 to March 2021, which comprised our unmasked and masked groups, respectively. The authors then calculated the incidence of endophthalmitis following IVI and evaluated the cases of post-injection endophthalmitis for both time periods. RESULTS: A total of 121,384 IVIs performed over the 2-year period of interest. Of these, 63,114 were unmasked and 58,270 were masked patient encounters. A total of 46 post-injection endophthalmitis cases were identified. Of these, 29 cases were from the unmasked period and 17 were from the masked period. This resulted in an incidence of endophthalmitis of 0.046% and 0.038% in the masked and unmasked groups, respectively. This difference did not rise to the level of statistical significance ( P = 0.1336). CONCLUSION: This study suggests that the incidence of post-injection endophthalmitis was not influenced by the implementation of ophthalmologist-patient face masking after IVI during the coronavirus disease 2019 pandemic.
Subject(s)
COVID-19 , Endophthalmitis , Intravitreal Injections , Masks , SARS-CoV-2 , Humans , Endophthalmitis/epidemiology , Endophthalmitis/prevention & control , Endophthalmitis/etiology , Intravitreal Injections/adverse effects , Retrospective Studies , COVID-19/epidemiology , COVID-19/prevention & control , Incidence , Male , Female , Aged , Middle Aged , Michigan/epidemiology , Angiogenesis Inhibitors/administration & dosage , Eye Infections, Bacterial/epidemiology , Eye Infections, Bacterial/prevention & control , Eye Infections, Bacterial/etiology , PandemicsSubject(s)
Cataract Extraction , Endophthalmitis , Eye Infections, Bacterial , Humans , Benchmarking , Endophthalmitis/epidemiology , Endophthalmitis/etiology , Endophthalmitis/drug therapy , Postoperative Complications/etiology , Risk Factors , Eye Infections, Bacterial/etiology , Eye Infections, Bacterial/complications , Anti-Bacterial Agents/therapeutic use , Cataract Extraction/adverse effects , Retrospective StudiesABSTRACT
BACKGROUND: Cataract surgical safety has improved over recent decades, with endophthalmitis rates before 2006 typically 0.13-0.15% compared with the most recent UK national estimate of 0.02%. There remains, however, substantial variation in reported rates from different centres. Due to the low event rate, this disparity may not be noticed and opportunities to improve therefore be missed. We propose a method of monitoring post-cataract endophthalmitis rates that would help centres with higher rates identify this. METHODS: A statistical tool, available to download or use online, permits comparison of local endophthalmitis rate with the estimated UK rate of 0.02%. Centres are encouraged to maintain a register of endophthalmitis cases, and when the number reaches a threshold (X cases), either in a certain time period or in a fixed number of procedures, then the centre can consider itself as an outlier and trigger local investigations to improve infection control. RESULTS: Example outputs are offered, such as for a unit doing 5000 cataracts annually, a value of X is suggested such that the third case of endophthalmitis (X = 3) in a 12-month period would give 85% confidence, the fourth case 90% confidence and the fifth case 95% confidence that the true endophthalmitis rate for that unit was higher than the national average. CONCLUSIONS: This statistical tool provides a basis for units to set a threshold number of cases of endophthalmitis within a given period that would trigger local processes, thus helping inform local monitoring processes for this rare but potentially catastrophic complication of cataract surgery.